Copyright Reports & Markets. All rights reserved.

Global Risperidone Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Risperidone

      • 1.1 Definition of Risperidone
      • 1.2 Risperidone Segment by Type
        • 1.2.1 Global Risperidone Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injectable
      • 1.3 Risperidone Segment by Applications
        • 1.3.1 Global Risperidone Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Schizophrenia
        • 1.3.3 Bipolar Disorder
      • 1.4 Global Risperidone Overall Market
        • 1.4.1 Global Risperidone Revenue (2014-2025)
        • 1.4.2 Global Risperidone Production (2014-2025)
        • 1.4.3 North America Risperidone Status and Prospect (2014-2025)
        • 1.4.4 Europe Risperidone Status and Prospect (2014-2025)
        • 1.4.5 China Risperidone Status and Prospect (2014-2025)
        • 1.4.6 Japan Risperidone Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Risperidone Status and Prospect (2014-2025)
        • 1.4.8 India Risperidone Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Risperidone
      • 2.3 Manufacturing Process Analysis of Risperidone
      • 2.4 Industry Chain Structure of Risperidone

      3 Development and Manufacturing Plants Analysis of Risperidone

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Risperidone Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Risperidone
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Risperidone Production and Capacity Analysis
      • 4.2 Risperidone Revenue Analysis
      • 4.3 Risperidone Price Analysis
      • 4.4 Market Concentration Degree

      5 Risperidone Regional Market Analysis

      • 5.1 Risperidone Production by Regions
        • 5.1.1 Global Risperidone Production by Regions
        • 5.1.2 Global Risperidone Revenue by Regions
      • 5.2 Risperidone Consumption by Regions
      • 5.3 North America Risperidone Market Analysis
        • 5.3.1 North America Risperidone Production
        • 5.3.2 North America Risperidone Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Risperidone Import and Export
      • 5.4 Europe Risperidone Market Analysis
        • 5.4.1 Europe Risperidone Production
        • 5.4.2 Europe Risperidone Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Risperidone Import and Export
      • 5.5 China Risperidone Market Analysis
        • 5.5.1 China Risperidone Production
        • 5.5.2 China Risperidone Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Risperidone Import and Export
      • 5.6 Japan Risperidone Market Analysis
        • 5.6.1 Japan Risperidone Production
        • 5.6.2 Japan Risperidone Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Risperidone Import and Export
      • 5.7 Southeast Asia Risperidone Market Analysis
        • 5.7.1 Southeast Asia Risperidone Production
        • 5.7.2 Southeast Asia Risperidone Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Risperidone Import and Export
      • 5.8 India Risperidone Market Analysis
        • 5.8.1 India Risperidone Production
        • 5.8.2 India Risperidone Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Risperidone Import and Export

      6 Risperidone Segment Market Analysis (by Type)

      • 6.1 Global Risperidone Production by Type
      • 6.2 Global Risperidone Revenue by Type
      • 6.3 Risperidone Price by Type

      7 Risperidone Segment Market Analysis (by Application)

      • 7.1 Global Risperidone Consumption by Application
      • 7.2 Global Risperidone Consumption Market Share by Application (2014-2019)

      8 Risperidone Major Manufacturers Analysis

      • 8.1 Janssen Pharmaceutica
        • 8.1.1 Janssen Pharmaceutica Risperidone Production Sites and Area Served
        • 8.1.2 Janssen Pharmaceutica Product Introduction, Application and Specification
        • 8.1.3 Janssen Pharmaceutica Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Teva
        • 8.2.1 Teva Risperidone Production Sites and Area Served
        • 8.2.2 Teva Product Introduction, Application and Specification
        • 8.2.3 Teva Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sun Pharmaceutical
        • 8.3.1 Sun Pharmaceutical Risperidone Production Sites and Area Served
        • 8.3.2 Sun Pharmaceutical Product Introduction, Application and Specification
        • 8.3.3 Sun Pharmaceutical Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Aurobindo
        • 8.4.1 Aurobindo Risperidone Production Sites and Area Served
        • 8.4.2 Aurobindo Product Introduction, Application and Specification
        • 8.4.3 Aurobindo Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Cipla
        • 8.5.1 Cipla Risperidone Production Sites and Area Served
        • 8.5.2 Cipla Product Introduction, Application and Specification
        • 8.5.3 Cipla Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Invent Farma Group
        • 8.6.1 Invent Farma Group Risperidone Production Sites and Area Served
        • 8.6.2 Invent Farma Group Product Introduction, Application and Specification
        • 8.6.3 Invent Farma Group Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Medichem
        • 8.7.1 Medichem Risperidone Production Sites and Area Served
        • 8.7.2 Medichem Product Introduction, Application and Specification
        • 8.7.3 Medichem Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Interquim
        • 8.8.1 Interquim Risperidone Production Sites and Area Served
        • 8.8.2 Interquim Product Introduction, Application and Specification
        • 8.8.3 Interquim Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 IPCA
        • 8.9.1 IPCA Risperidone Production Sites and Area Served
        • 8.9.2 IPCA Product Introduction, Application and Specification
        • 8.9.3 IPCA Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 RPG
        • 8.10.1 RPG Risperidone Production Sites and Area Served
        • 8.10.2 RPG Product Introduction, Application and Specification
        • 8.10.3 RPG Risperidone Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Sharon
      • 8.12 Torrent Pharmaceuticals
      • 8.13 Temad
      • 8.14 Wuxi Jida
      • 8.15 Changzhou Siyao Pharmaceuticals
      • 8.16 Ningbo Team Pharm
      • 8.17 Zhejiang Huahai Pharmaceutical
      • 8.18 TIPR
      • 8.19 Qilu Pharmaceutical

      9 Development Trend of Analysis of Risperidone Market

      • 9.1 Global Risperidone Market Trend Analysis
        • 9.1.1 Global Risperidone Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Risperidone Regional Market Trend
        • 9.2.1 North America Risperidone Forecast 2019-2025
        • 9.2.2 Europe Risperidone Forecast 2019-2025
        • 9.2.3 China Risperidone Forecast 2019-2025
        • 9.2.4 Japan Risperidone Forecast 2019-2025
        • 9.2.5 Southeast Asia Risperidone Forecast 2019-2025
        • 9.2.6 India Risperidone Forecast 2019-2025
      • 9.3 Risperidone Market Trend (Product Type)
      • 9.4 Risperidone Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Risperidone Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Risperidone market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Risperidone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Risperidone market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Risperidone in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Risperidone manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Janssen Pharmaceutica
        Teva
        Sun Pharmaceutical
        Aurobindo
        Cipla
        Invent Farma Group
        Medichem
        Interquim
        IPCA
        RPG
        Sharon
        Torrent Pharmaceuticals
        Temad
        Wuxi Jida
        Changzhou Siyao Pharmaceuticals
        Ningbo Team Pharm
        Zhejiang Huahai Pharmaceutical
        TIPR
        Qilu Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Oral
        Injectable

        Segment by Application
        Schizophrenia
        Bipolar Disorder

        Buy now